Steerable needles market seen reaching $2.69 billion by 2030

The steerable needles market is projected to grow from $1.76 billion in 2025 to $1.93 billion in 2026, according to The Business Research Company. The report points to minimally invasive procedures, imaging advances, and robotic surgery as the main forces behind the market’s expansion through 2030.

Why it matters: - Steerable needles are becoming more important in procedures that require precise navigation to hard-to-reach targets. - The market’s growth reflects rising demand for minimally invasive care, where accuracy can reduce tissue damage and recovery time. - The forecast suggests more use of image-guided and robot-assisted tools in surgery and interventional medicine.

What happened: - The Business Research Company released its 2026 steerable needles market report on August 27, 2026. - The market is projected to rise from $1.76 billion in 2025 to $1.93 billion in 2026, a 9.7% compound annual growth rate. - The report forecasts the market will reach $2.69 billion by 2030, growing at an 8.7% CAGR. - The report is available in full here. - A free sample is available here.

The details: - Steerable needles are designed to change direction inside the body to reach targets that straight needles cannot access easily. - The needles typically use imaging guidance such as ultrasound, MRI or fluoroscopy. - The report says these tools can improve intervention accuracy, reduce trauma to surrounding tissue and support better outcomes in complex procedures. - Growth in the historical period was driven by rising use of minimally invasive procedures, imaging advances, interventional radiology, precision surgical instruments and robotic-assisted surgery. - Future growth is expected to come from AI-assisted surgical navigation, demand for complex tumor targeting, more robotic surgery platforms, greater investment in advanced interventional devices and efforts to reduce procedural complications. - The report flags expanded image-guided needle navigation, integration with robotic surgical systems, broader minimally invasive use, real-time trajectory control and a stronger focus on procedural precision and safety as key trends. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and trend analysis.

Between the lines: - The market forecast ties directly to a wider shift in medicine toward image-guided, less invasive procedures. - Stronger growth in Asia-Pacific may reflect faster adoption of advanced surgical and interventional technologies across emerging health systems. - The emphasis on AI and robotic systems suggests steerable needles are moving from niche tools toward part of a broader precision-surgery stack.

What's next: - Adoption should increase as hospitals and surgical centers expand minimally invasive and robot-assisted procedures. - Product development is likely to focus on better navigation, tighter control and lower complication rates. - Market competition may intensify as vendors pair steerable needles with imaging, AI and robotic platforms.

The bottom line: - Steerable needles are moving into a faster-growth phase as precision medicine and minimally invasive surgery keep expanding.